FDA Inspection
Piedmont Henry HospitalPiedmont Henry Hospital – FDA Inspection, Mar 21, 2022
Record Details
This FDA Inspection record concerns Piedmont Henry Hospital, with an inspection on March 21, 2022, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Piedmont Henry Hospital
- Inspection Date
- March 21, 2022
- Product Type
- Biologics
View Company Profile
ID · 4b57a6f4-c61b-4ca1-b363-8f240d82f963
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1165417
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Piedmont Henry Hospital
3| Date | Classification | Office | Project area |
|---|---|---|---|
| February 1, 2024 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 9, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 20, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Piedmont Henry Hospital
- FDA Inspection 1228856 - 2024-02-01
- FDA Inspection 1076837 - 2019-01-09
- FDA Inspection 997989 - 2017-01-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.